at general check-ups conducted by municipalities or employers in Japan. Patients with chronic HBV or HCV infection should be managed to receive optimal anti-viral therapy and regular surveillance for early detection of HCC following a guideline established by the Japan Society of Hepatology (4) (5) (6) . The surveillance recommendations for early detection of HCC include combining testing for tumor markers, such as α-fetoprotein (AFP) and des-γ-carboxy prothrombin (DCP), with diagnostic imaging modalities, such as ultrasound, contrast-enhanced computed tomography (CT), or magnetic resonance imaging (MRI), depending on the patient's age and progression of hepatic fibrosis, both of which are recognized as high risk factors for HCC (4) (5) (6) (7) .
However, it is estimated that many patients have either never been tested for HBV and HCV infections or remain untreated despite their known HBV or HCV diagnosis (8) . In addition, it appears that the occurrence rate of HCC has been increasing recently in patients who are not infected with HBV or HCV but have a history of alcohol intake, diabetes mellitus, obesity, or non-alcoholic steatohepatitis (NASH) (9, 10) . Therefore, it is of concern that the traditional algorithm to detect early stage HCC in high-risk patients may not be useful for these individuals; consequently, the prognosis of HCC may worsen in the future.
The aim of this study is to characterize patients with HCC in the central region of Saitama to investigate the relationship between regular hospital visits and the prognosis of HCC after initial diagnosis, identify high-risk patients, and suggest improvements to the medical care system for avoiding deterioration in the prognosis of HCC in community health.
MATERIALS AND METHODS

Statement of Ethics
This study was approved by a suitably constituted ethics committee at our facility and conformed to the provisions of the Declaration of Helsinki. All patients provided informed consent prior to inclusion in the study.
Settings
This was a single-center, retrospective, case-control study conducted at our hospital, which is accredited as a key hospital in the east-central region in Saitama, 40 km from Tokyo, Japan. Our hospital is equipped with ultrasound, multi-detector row CT, 1.5 tesla MRI, and offers liver resection, radio-frequency ablation (RFA), transcatheter arterial chemoembolization (TACE), molecular targeted therapy, and radiation therapy for patients with HCC.
Patients
In total, 103 patients who were initially diagnosed with HCC between January 2012 and June 2016 were classified into 3 groups based on hospital visits occurring 1 year before their diagnosis. Group A composed of patients who had regular hepatologist visits, group B of patients with regular visits to other hospital divisions, and group C of patients with no regular hospital visits.
Methods and Definitions
Regular hospital visits were defined as visitations to a hospital (general such as our hospital, specialized, or clinics) to receive examinations or treatments for liver or other diseases once or more in the year before diagnosis of initial HCC. Hepatologist visits were defined as visits to an attending physician who was a board-certified gastroenterologistof the Japanese Society of Gastroenterology, board-certified surgeon in gastroenterology of the Japanese Society of Gastroenterological Surgery, or board-certified surgeon of the Japan Surgical Society who has engaged in the treatment of liver diseases, and was a board-certified member of the Japan Society of Hepatology.
Surveillance for HCC by imaging modalities was defined as a systematic examination at least once a year by ultrasound, CT, or MRI for early detection. Fortuitous detection of HCC by examinations for other purposes was excluded, for example, ultrasound for initial or temporal abnormalities related to liver function, chest CT for surveillance of lung cancer, and cardiac ultrasonography for heart diseases.
Statistical Analysis
The relationship between regular hospital visits and survival rates was analyzed using the generalized Wilcoxon test. For analyzing the relationships between the type of hospital visits and backgrounds of patients before diagnosis, condition of patients at diagnosis, and treatments after diagnosis of initial HCC, categorical variables and quantitative variables were analyzed using the χ 2 test and Kruskal-Wallis test, respectively. Additionally, Bonferroni correction and the Steel-Dwass test were applied for adjustment of categorical variables and quantitative variables, respectively. All statistical tests were performed using Ekuseru-Toukei 2015 (Social Survey Research Information Co., Ltd., Tokyo, Japan).
RESULTS
Of the 103 patients diagnosed with HCC in this study, 41 (39.8%), 50 (48.5%), and 12 (11.7%) patients were classified into group A (regular hepatologist visits), group B (regular visits to other hospital divisions), and group C (no regular hospital visits), respectively ( Figure 1) Non-viral cause n=14 (7) Non-viral cause n=34 (26)
Non-viral cause n=6 (5) Group B (regular visits to other divisions) n=41 (19) Group C (no hospital visits) n=12 (8) Figure 2 ).
The relationship between the types of hospital visits and backgrounds, hepatic reserve, HCC status, and initial treatment for HCC is shown in (Figure 1 ).
In this study, 6 patients had achieved sustained virologic response (SVR) by previous interferon (IFN) monotherapy or ribavirin combination therapy for chronic HCV infection; 5 of them were classified into group A and 1 was classified into group B. Age, body mass index, history of alcohol intake, and history of diabetes mellitus were not related with hospital visits.
Regarding the condition of patients at diagnosis, the performance status was poor in group C compared with group A. Hepatic encephalopathy (hepatic coma) and ascites did not show statistical significance; however, serum levels of prothrombin time and albumin in group C were unfavorable, and ChildPugh classification was poorest in group C.
The status of HCC, such as maximum tumor size, number of tumors, invasion to intra-hepatic portal vein, and extra-hepatic spread was more favorable in group A, and ruptured HCC was not found in group A. Consequently, the TNM Classification of Tumors (TNM) stage was earliest in group A compared group B or group C. Additionally, the Japan integrated staging (JIS) score and Barcelona clinic liver cancer (BCLC) staging were most advantageous to survival after initial diagnosis of HCC in group A.
Serum levels of AFP and DCP were examined at the diagnosis of HCC in 94 and 92 patients, respectively, and they differed significantly among groups (p=0.049 in AFP and p=0.011 in DCP), with patients in group C more likely to have high serum levels and high sensitivity (90.0% and 70.0%, respectively). In comparing management before initial diagnosis of HCC between groups A and B, anti-viral therapy, such as IFN-based therapy and nucleoside analog therapy was performed at low rates for patients with viral infection in group B (12.5%).
Regarding surveillance for early detection of HCC, testing for the combination of AFP and DCP and examination by imaging modalities were more common in group A (78.0 and 97.6%, respectively) than in group B (10.0% and18.0%, respectively).
One (2.4%) of the patients in group A, 41 (82.0%) in group B, and all patients in group C who did not receive surveillance for HCC by imaging modalities had fortuitous detections of HCC by ultrasound in 23 cases, CT in 23 cases, and MRI in 5 cases for other purposes. Two HCC diagnoses from breast CT and 1 cardiac ultrasonography were included in these results.
DISCUSSION
Several limitations and biases of our study need to be considered. The sample size of this study is small because this study was conducted in a single hospital, the only institution that can offer treatments for HCC in a limited geographic region. However, because few patients visit our hospital from other areas to receive treatment for HCC, the results of this study are indicative of conditions in the region. The modality and period of surveillance for early detection of HCC have not been standardized worldwide. Therefore, 2 types of surveillance methods for HCC were set in this study: presence or absence of testing for the combination of AFP and DCP at least once a year and presence or absence of systematic examination at least once a year by imaging examinations such as ultrasound, CT, or MRI.
The effectiveness of surveillance for HCC has been established in (very) high-risk patients that have HBV or HCV infection and cirrhosis in Japan (4-6) and in other countries (11, 12) . In Japan, surveillance for "early" detection of HCC using tumor markers, ultrasound, CT, or MRI is well established with the support of the national health insurance system. This study showed that regular hospital visits were associated with a favorable prognosis for initial HCC, which may be related to the detection of HCC at an early stage because of substantial surveillance for early detection of HCC using the combination of AFP and DCP testing as well as examinations using imaging modalities. Furthermore, stable hepatic reserve is likely related to suitable management for liver damage by regional clinicians before the occurrence of HCC. It is notable that groups B and C might include patients without chronic liver diseases before the occurrence of HCC. Nevertheless, when focusing only on effects in viral-related cases, group A comprised of more patients with a history of anti-viral therapy and had a more advantageous hepatic reserve (13, 14) . Moreover, an earlier stage of HCC and stable hepatic reserve, which were related with regular hospital visits before occurrence of HCC, might be more amenable to curative initial treatments for HCC and contribute to an improved prognosis after the diagnosis. Of note, because patients in group B tended to have larger sized tumors compared with group A, the number of hepatic resections exceeded that of RFA in this study.
The accuracy of regular hospital visits, which this study suggested as a single prognostic factor, is not superior to those of the major staging systems, such as BCLC, cancer of the liver Italian program, and JIS score, which are composed of performance status, various tumor characteristics (eg, size, number, vessel invasion, and level of AFP), and hepatic reserve (15) (16) (17) . However, it is notable that regular hospital visits are unique as a pre-diagnostic variable in that they are under patient control, unlike other irrevocable conditions of patients at diagnosis, such as tumor stage and hepatic reserve.
Conversely, patients' low awareness of their risk of HCC might render early detection more difficult. It was suggested that patients without the opportunity to visit a hospital often received sub-optimal treatments after their initial diagnosis of HCC because of poor hepatic reserve and delay in detection of HCC. From the start, specific reasons, such as an abnormality in liver function tests or HBV or HCV infection, appear to be needed for patients to decide upon a visit to a clinician, particularly a hepatologist. However, practically, the patients are often asymptomatic and are overlooked until they receive liver tests for a possibly unrelated reason. Unfortunately, once the patient has symptoms related to liver damage, such as ascites, jaundice, or hepatic coma, their underlying liver diseases have a high risk of progression.
Regarding this issue, it has been recognized that the major causes of HCC in Japan (80% or more) were associated with HCV or HBV infection; however, recent epidemiological reports indicate that cases of HCC not associated with these viral infections or "cryptogenic" HCC are increasing (2, 18) . A review composed of a large sample size of studies showed that non-viral HCC accounted for 15% of HCC in Japan (18) . In fact, 52.4% of patients had non-viral HCC, and patients without HCV or HBV infection were less likely to receive regular hepatologist visits in this study.
For the gender difference in HCC, it has been reported that survival in HCC of women is better compared to men; however, the reason had not been clearly elucidated (19, 20) . According to previous research that implied the cause of the sex difference in survival with HCC, women were more closely followed-up compared to men in the detection of early-stage HCC among high-risk patients (19) . Our study also revealed that males were less likely to receive regular hepatologist visits. It is a particularly concerning fact in this region that 15 (93.8%) of 16 males in group B did not visit a hepatologist until HCC occurred although they had HCV or HBV infection (Figure 1 ).
Recently, it has also been recognized that surveillance for HCC is required even in patients with HCV infection who achieved SVR by treatment containing IFN because of their residual susceptibility for the development of HCC (21) . In this study, 1 of 6 patients with SVR for HCV had neither hepatologist visits nor surveillance for HCC, and only this patient died of HCC during this study period.
These trends might explain the finding that more than onehalf of patients with HCC in this study had not been managed by a hepatologist and did not undergo surveillance for HCC until HCC occurred. The difficulty of detection of HCC can be summarized into 4 subgroups shown as a, b, c, and d in Figure 1 .
Subgroup a is composed of cases that are managed by hepatologists following the optimal surveillance method for detection of early-stage HCC in patients with HBV or HCV infection or non-viral chronic liver diseases (patients in group A in this study) (5) . This system has been already established and will be continually observed in the future.
Subgroup b includes cases with HBV or HCV infection or nonviral chronic liver diseases that are well managed by clinicians in other divisions. Advising these clinicians to avoid overlooking HCC is effective, but they may nevertheless be more likely to fail to notice the occurrence of HCC compared to hepatologists.
Subgroup c consists of patients who should be considered at (high) risk for HCC. This group includes patients infected with HBV or HCV who regularly visit other hospital divisions or do not visit the hospital and do not undergo surveillance for HCC despite the viral status. Here 80% of patients in this subgroup were males. If these cases can receive optimal management, the prognosis of HCC may be improved.
Subgroup d comprises of patients with HCC who are not associated with viral infection or may be cryptogenic. They are not under surveillance for HCC. Even if these patients visit the hospital regularly, there may be few opportunities to suspect the occurrence of HCC. When HCC is incidentally detected, the stage is often advanced. Because it is estimated that this patient type is increasing, the traditional surveillance method to detect early stage HCC, which was established for patients with (high) risk of HCC, may not have widespread utility; consequently, this may adversely affect the overall prognosis of HCC in Japan in the future (10).
It is ideal that patients with risk factors for HCC, such as infection with HBV and HCV, alcohol intake, diabetes mellitus, obesity, and NASH, are followed in community health. Nevertheless, results from this study do not suggest concrete methods to identify patients in a large population with unknown risk of HCC or cryptogenic HCC. Ultrasound and CT are definitive and indispensable assessments for early detection of HCC in high-risk patients (22) . However, ultrasound of the liver can be technically difficult for clinicians in other divisions (22) . Furthermore, CT would not be performed without a reason in patients at an unclear risk for HCC because of cost, radiation exposure, and potential iodine allergy (22) . The optimal timing for these imaging examinations is also unclear.
Examination using only tumor markers, such as AFP and DCP, has been suggested as an inadequate modality for "early" detection of HCC in patients with high risk for HCC because of their unreliable sensitivity and/or specificity (23) . The sensitivity and specificity of AFP for initial detection of HCC is 61% and 81%, respectively, and those of DCP are 74% and 86%, respectively. However, in this study, the serum level and sensitivity of AFP and DCP at the diagnosis of HCC tended to be higher in group C compared with group A (23). It is highly probable that the advanced stage of HCC restricts the more effective treatments for HCC, such as hepatic resection, RFA, and TACE as well as directly impacts the prognosis (15) . Consequently, the patients without regular hospital visits had poor prognoses. Although their utility for early detection of HCC is limited, in countries with a high incidence of HCC, routine measurements of AFP, DCP, or both may be one of the few pragmatic options for a large population with an unknown risk for HCC in terms of cost, safety, and simplicity to provide the chance of any aggressive treatment, which is more effective than palliative care for patients with initial HCC.
In conclusion, in the regional community, regular hospital visits, particularly hepatologist visits, may improve the prognosis of initial HCC. In particular, regular hepatologist visits for male and non-virally infected patients should be promoted. A national prospective study to establish a method for detection of early stage HCC in various risk groups should be considered.
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